Does Botulinum Toxin Type-A Injection an Effective Way of Relieving Pain in Myofascial Pain Syndrome Patients or Not

In this research prilocaine and botulinum toxin (BoNT-A) interventions prospectively compared to find out the effect of BoNT-A injection on myofascial pain syndrome (MPS). The main question it aims to answer is: Does Botulinum Toxin Type-A an Effective Way of Relieving Pain in Myofascial Pain Syndrome or not? For this purpose thirty-eight patients randomly assigned into two study groups. While BoNT-A injection group (BIG group n=19) treated with 20 units of toxin to each trigger point (TP), remaining treated with 2 ml prilocaine (PIG group n=19) with same procedure. Pre-treatment, 2nd and 6th weeks findings were clinically recorded.

NCT Number	NCT06899438
Lead Sponsor	Bursa City Hospital
Conditions	Myofacial Pain Syndromes
Enrollment	38 participants
Start Date	2009-08-26
Primary Completion	2010-01-26 (estimated)
Study Completion	2010-01-26 (estimated)
Updated on ClinicalTrials.gov	2026-01-09